# Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers

> **NCT00742820** · PHASE1 · COMPLETED · sponsor: **Fresenius Medical Care North America** · enrollment: 46 (actual)

## Conditions studied

- Hyperphosphatemia

## Interventions

- **DRUG:** Calcium Acetate Oral Solution 667 mg per 5 mL
- **DRUG:** Calcium Acetate 667 mg GelCaps
- **DIETARY_SUPPLEMENT:** Calcium Citrate 950 mg Caplets

## Key facts

- **NCT ID:** NCT00742820
- **Lead sponsor:** Fresenius Medical Care North America
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00742820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00742820, "Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00742820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*